Keyphrases
ERK2
100%
Brain-derived Neurotrophic Factor
100%
Distinct Roles
100%
ERK5
100%
Neurotrophic Factor Expression
100%
Neurotrophins
30%
Dysregulation
20%
MEK1
20%
Constitutively Active
10%
Signaling Pathway
10%
Neuroprotection
10%
Mitogen-activated Protein Kinase
10%
Primary Astrocytes
10%
Alzheimer's Disease
10%
Neurodegenerative Diseases
10%
Factor Level
10%
Pharmacological Approaches
10%
Specific Inhibitor
10%
Long-term Potentiation
10%
Neuronal Cells
10%
RNA Interference
10%
U0126
10%
MEK5
10%
C6 Glioma Cells
10%
Inhibitory Role
10%
Non-neuronal Cells
10%
Opposite Effects
10%
Negative Control
10%
Molecular Approaches
10%
Long-term Thinking
10%
Active Site mutant
10%
PD184352
10%
Neuroscience
Mitogen Activated Protein Kinase 3
100%
Brain-Derived Neurotrophic Factor
100%
Mitogen Activated Protein Kinase 7
100%
Neurotrophic Factor Expression
100%
Neurotrophin
30%
Transfection
20%
Neuroprotection
10%
Cell Signaling
10%
Astrocyte
10%
Mitogen-Activated Protein Kinase
10%
Alzheimer's Disease
10%
Neurodegenerative Disorder
10%
Microglia
10%
Long-Term Potentiation
10%
U0126
10%
Messenger RNA
10%
Pharmacology, Toxicology and Pharmaceutical Science
Mitogen Activated Protein Kinase 3
100%
Mitogen Activated Protein Kinase 7
100%
Brain Derived Neurotrophic Factor
100%
Neurotrophic Factor Expression
100%
Neurotrophin
30%
Disease
20%
Neuroprotection
10%
Alzheimer's Disease
10%
1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene
10%
2 (2 Chloro 4 Iodoanilino) N Cyclopropylmethoxy 3,4 Difluorobenzamide
10%
Messenger RNA
10%